Abstract |
Sertoli cell tumors are a rare malignancy which account for approximately 1.5 % of all testicular tumors. Although malignant Sertoli cell tumors are uncommon, they are associated with a poor prognosis. So far 36 cases of malignant courses of disease have been described. We present a patient with a lymphogenic metastasized Sertoli cell tumor, who 24 months after orchiectomy and extended retroperitoneal lymphadenectomy is relapse-free.
|
Authors | K Günzel, H Wegner, H Cash, P Lohneis, C Kempkensteffen, K Miller, S Hinz |
Journal | Der Urologe. Ausg. A
(Urologe A)
Vol. 54
Issue 8
Pg. 1115-7
(Aug 2015)
ISSN: 1433-0563 [Electronic] Germany |
Vernacular Title | Maligner Sertoli-Zell-Tumor des Hodens. |
PMID | 25821170
(Publication Type: Case Reports, English Abstract, Journal Article)
|
Topics |
- Adult
- Combined Modality Therapy
(methods)
- Humans
- Lymph Node Excision
(methods)
- Male
- Orchiectomy
(methods)
- Sertoli Cell Tumor
(pathology, secondary, surgery)
- Testicular Neoplasms
(pathology, secondary, surgery)
- Treatment Outcome
|